NEW DELHI - Diethylene glycol (DEG) is an organic compound that is commonly used as an industrial solvent in antifreeze mixtures and brake fluids. But, in India, DEG is ending up with worrying frequency where it should never be – in cough syrups for children.
The repeated presence of this toxic substance in medicines has had devastating, fatal consequences in India and abroad, while also bringing the country’s lax drug regulatory set-up under intense scrutiny.
In the latest instance of such contamination, at least 22 children have been killed since September in the Indian states of Madhya Pradesh and Rajasthan after consuming Coldrif,
The most recent of these deaths occurred on Oct 8 when two children from Madhya Pradesh’s Chhindwara district died while undergoing treatment in Nagpur, a city in the adjacent state of Maharashtra.
Coldrif is produced by Tamil Nadu-based Sresan Pharmaceuticals, a relatively small manufacturer.
Cough syrups are made with propylene glycol (PG), a colourless and viscous liquid that is used as a solvent for syrupy medicines. It is available in two grades: pharmaceutical and commercial.
The pharmaceutical variant has a strictly controlled presence of DEG, if any, unlike the cheaper commercial kind, which has far higher levels of the compound, making it unfit for human consumption. Manufacturers, knowingly or unknowingly, use commercial-grade PG when making cough syrups to cut costs.
Even small amounts of DEG can prove fatal for children, with kidney failure a common occurrence. The syrup in question – Coldrif – contained 48.6 per cent DEG, far exceeding the maximum permissible limit of 0.1 per cent.
Over the years, DEG in Indian-made cough syrups has claimed the l...


1 year ago
194



English (US)